Key Insight on the Importance of Low CRA Turnover from Scimega CEO, Julie Martin
CEO, Julie Martin Shares Key Insights on the Importance of Low CRA Turnover to the Overall Success of your Oncology…
A Word From Dr. Stephen Welch – A Reverse Feasibility Champion
A Word From Dr. Stephen Welch – A Reverse Feasibility Champion
Optimizing North America For Your Oncology Trials
Optimizing North America For Your Oncology Trials
The Reverse Feasibility Program Explained
The Reverse Feasibility Program Explained